Location History:
- Cambridge, MA (US) (1989 - 1999)
- Weston, MA (US) (2000 - 2004)
- Cohasset, MA (US) (2005 - 2016)
Company Filing History:
15 out of 130 
13 out of 13 
4 out of 12 
Years Active: 1989-2016
Title: Barbara P Wallner: A Trailblazer in Patents and Innovations
Introduction:
Barbara P Wallner, based in Cambridge, MA (US), is a prolific inventor and patent holder with a remarkable track record of 34 patents to her name. Her groundbreaking research in the fields of medicine and pharmaceuticals has paved the way for significant advancements and breakthroughs. Let's explore her latest patents, career highlights, notable collaborations, and the impact of her work in the industry.
Latest Patents:
One of Barbara P Wallner's recent patents is titled "Salts of isophosphoramide mustard and analogs thereof." This patent encompasses the discovery of crystalline compounds, demonstrating Formula (I), which holds potential in various pharmaceutical applications. Another noteworthy patent is the "Method for controlling angiogenesis in animals," which focuses on the utilization of organic arsenical compounds to inhibit angiogenesis in diverse disease conditions.
Career Highlights:
Barbara P Wallner's remarkable career spans several notable companies, including Biogen, Incorporated, and Point Therapeutics, Inc. At these organizations, she has contributed significantly to their research and development efforts, leading to groundbreaking innovations and patents in the medical and pharmaceutical fields.
Collaborations:
Throughout her career, Barbara P Wallner has collaborated with esteemed professionals in the industry. Notably, her work has been enriched through collaborations with Glenn T Miller and R Blake Pepinsky. These collaborative efforts have fostered cross-disciplinary advancements, combining diverse expertise to tackle complex challenges and achieve pioneering solutions.
Conclusion:
Barbara P Wallner's impressive portfolio of 34 patents showcases her pioneering spirit, immense talent, and dedication to advancing medical and pharmaceutical research. Her latest patents, such as those focusing on isophosphoramide mustard salts and angiogenesis control, illustrate her ongoing commitment to innovation and the potential to revolutionize the industry. Through her career highlights and collaborations with esteemed colleagues, Barbara has made a lasting impact and continues to be an inspiration to aspiring inventors and researchers in the field.
Please note: The information provided in this article is based on publicly available data.